logo
logo
Sign in

Alcohol-Dependency Treatment Market Business Strategies And Opportunities With Key Players Analysis 2019-2026

avatar
[email protected] rashipande23

This Alcohol-Dependency Treatment market research analysis report begins with a basic introduction of the 2020 market segmentation, future scenario, industry growth rate, and industrial opportunities. The report forecasts the innovative applications of Alcohol-Dependency Treatment market on the basis of these estimations. Company profile comprises parameters such as company synopsis, commercial synopsis, work strategy and planning, SWOT analysis and present developments. The report gives out an outlook of the business chain structure and explains the industry condition, at that point dissects the market size and conjecture by item, district and market application.

Market Analysis: Global Alcohol-Dependency Treatment Market

Global alcohol-dependency treatment market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and untapped emerging economies are the key factors that fueling the market growth.

Market Definition: Global Alcohol-Dependency Treatment Market

Alcohol-dependency is also known as alcohol use disorder chronic consumption of alcoholic beverages at a level that interferes with physical or mental health. It can lead to health and social problem and causes negative emotions, impulsive behavior, craving and withdrawal syndrome.

According to the source from the Our World in Data, it is estimated that globally, around 185,000 people died directly from alcohol use disorders in 2017. Improvement in treatment rates and healthcare infrastructure are also expected to propel the growth of the market

Market Drivers

High prevalence of alcohol abuse disorder worldwide and vulnerable adult population is propelling the growth of this market

Change in life style and non-stringent regulation on sale of alcohol to the minors

New innovation and emerging new markets is boosting the market growth

High demand of disease specific novel treatment can also act as a market driver

The competitive scenario of market and strategic collaborations may boost the market position

Market Restraints

Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceuticals is acting as a challenging factor for the growth of this market

Low healthcare budget in some developing countries is hamper the market growth

Get Exclusive Sample Report + All Related Graphs & Charts Herehttps://www.databridgemarketresearch.com/request-a-sample?dbmr=global-alcohol-dependency-treatment-market&raksh

Key Market Players:

Few of the major competitors currently working in the global alcohol-dependency treatment market are Alkermes, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Mylan N.V, Glenmark Pharmaceuticals Ltd, Curemark, LLC, Chronos Therapeutics Ltd, BioCorRx, Inc, Bionex Pharmaceuticals LLC, Cerecor Inc , Opiant Pharmaceuticals, Omeros Corporation, MONTISERA LTD, Kinnov Therapeutics, Indivior PLC, Bristol-Myers Squibb Company, Otsuka Holdings Co., Ltd, H. Lundbeck A/S and others.

Segmentation: Global Alcohol-Dependency Treatment Market

By Type

Mild

Moderate

Severe

By Therapy

Cognitive Behavioral Therapy

Psychotherapy

By Drugs

Naltrexone

Antabuse

Acamprosate

Others

By Route of Administration

Oral

Injectable

By End Users

Hospitals

Rehabilitation Centers

Others

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Geography

North America

South America

Europe

Asia-Pacific

Middle East & Africa

Table Of Contents Is Available Here@ https://www.databridgemarketresearch.com/toc?dbmr=global-alcohol-dependency-treatment-market&raksh

Key Developments in the Market:

In January 2019, H. Lundbeck A/S received an approval from the Japan’s Ministry of Health, Labor and Welfare (MHLW) for Selincro (nalmefene hydrochloride) for treatment to reduce alcohol consumption in alcohol-dependent patients. The approval of Selincro represents significantly improve the lives of millions of patients suffering from alcohol addiction throughout the Japan.

In July 2017, Opiant Pharmaceuticals reported topline result of phase I trial of OPNT002 which is a tranasally dosed (IN) formulation of the opioid antagonist naltrexone hydrochloride is developing for the treatment of Alcohol Use Disorder (AUD). The trial demonstrated increased the rate of absorption of intranasal naltrexone with no serious adverse event.

Competitive Analysis:

Global alcohol-dependency treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares global alcohol-dependency treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

 

collect
0
avatar
[email protected] rashipande23
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more